Hester Biosciences has informed about transcripts of Earnings Conference Call held by the Management of the Company with investors on 7 May 2019 at 2.00 p.m. to discuss the Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31 March 2019.
The above information is a part of company’s filings submitted to BSE.